Samuel Lai, Ph.D.
Assistant Professor, 2010-
Eshelman School of Pharmacy (Molecular Pharmaceutics); Primary Appointment, 2010 -
Biomedical Engineering; Adjunct Appointment, 2010 -
Lineburger Cancer Center; Member, 2010 -
Center for Infectious Disease; Member, 2010 -
University of North Carolina at Chapel Hill
Office: Genetic Medicine Bldg (GMB) Rm 1062
Mailing Address: Campux Box 7362, UNC, Chapel Hill , NC 27599-7360
T: (919) 966-3024
F: (919) 843-1232
Biography: Dr. Lai was born in Hong Kong and spent his childhood in both Hong Kong and Vancouver. After completing high school at Phillips Academy, Andover, he attended Cornell University and received his BS in Chemical & Biomolecular Engineering in 2003. He then undertook doctoral studies at Johns Hopkins University, receiving his PhD in Chemical & Biomolecular Engineering in 2007. Following a one-year postdoc, he became a research assistant professor at Johns Hopkins in fall 2008 before joining the UNC Eshelman School of Pharmacy in fall 2010. Dr. Lai's previous research focused on nanoparticle-based delivery of bioactive molecules to mucosal tissues. He helped pioneer the development of mucus-penetrating particle (MPP) technology, a breakthrough that formed the basis of Kala Pharmaceuticals, launched in 2009 based on funding from a syndicate of leading VC firms.